期刊
PARASITOLOGY RESEARCH
卷 105, 期 5, 页码 1223-1229出版社
SPRINGER
DOI: 10.1007/s00436-009-1542-6
关键词
-
类别
资金
- Fundacao para a Ciencia a Tecnologia-FCT [POCI/CVT/61090/2004, PTDC/CVT/72624/2006, SFRH/BPD/26491/2006]
- Fundação para a Ciência e a Tecnologia [SFRH/BPD/26491/2006, PTDC/CVT/72624/2006, POCI/CVT/61090/2004] Funding Source: FCT
African trypanosomiasis (AT), also known as sleeping sickness in humans and Nagana in animals, is a disease caused by the protozoan parasite Trypanosoma brucei. AT is an extremely debilitating disease in human, cattle, and wild animals, and the treatment is difficult with frequent relapses. This work shows that BALB-c mice immunized intramuscularly with a single dose (100 mu g) of a plasmid DNA encoding the 5'-terminal region of the trans-sialidase (nTSA) gene of T. brucei brucei are able to produce IgG antibodies that bind to the bloodstream form of T. brucei-protein extract and recognize the recombinant nTSA protein, expressed in Escherichia coli. Furthermore, this DNA vaccination process was able to protect 60% of mice submitted to a challenge assay with the infective form of T. brucei brucei parasites. These results demonstrate that a DNA vaccine coding for trans-sialidase from T. brucei is potentially useful in the prophylaxis of AT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据